These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. Tooley AS; Kazyken D; Bodur C; Gonzalez IE; Fingar DC J Biol Chem; 2021 Aug; 297(2):100942. PubMed ID: 34245780 [TBL] [Abstract][Full Text] [Related]
3. The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists. Bodur C; Kazyken D; Huang K; Ekim Ustunel B; Siroky KA; Tooley AS; Gonzalez IE; Foley DH; Acosta-Jaquez HA; Barnes TM; Steinl GK; Cho KW; Lumeng CN; Riddle SM; Myers MG; Fingar DC EMBO J; 2018 Jan; 37(1):19-38. PubMed ID: 29150432 [TBL] [Abstract][Full Text] [Related]
4. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396 [TBL] [Abstract][Full Text] [Related]
5. Growing knowledge of the mTOR signaling network. Huang K; Fingar DC Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279 [TBL] [Abstract][Full Text] [Related]
6. Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice. Jiang H; Westerterp M; Wang C; Zhu Y; Ai D Diabetologia; 2014 Nov; 57(11):2393-404. PubMed ID: 25120095 [TBL] [Abstract][Full Text] [Related]
7. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. Soliman GA; Acosta-Jaquez HA; Dunlop EA; Ekim B; Maj NE; Tee AR; Fingar DC J Biol Chem; 2010 Mar; 285(11):7866-79. PubMed ID: 20022946 [TBL] [Abstract][Full Text] [Related]
8. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957 [TBL] [Abstract][Full Text] [Related]
9. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
10. Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease. Shi F; Collins S Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511253 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of Lkb1 and mTOR in adipose tissue. Xu Z; You W; Wang F; Wang Y; Shan T Adipocyte; 2019 Dec; 8(1):26-30. PubMed ID: 30318987 [TBL] [Abstract][Full Text] [Related]
12. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition. Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229 [TBL] [Abstract][Full Text] [Related]
14. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). García-Martínez JM; Alessi DR Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875 [TBL] [Abstract][Full Text] [Related]
15. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle. Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856 [TBL] [Abstract][Full Text] [Related]
16. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass. Alejandro EU; Bozadjieva N; Blandino-Rosano M; Wasan MA; Elghazi L; Vadrevu S; Satin L; Bernal-Mizrachi E Diabetes; 2017 Aug; 66(8):2150-2162. PubMed ID: 28546423 [TBL] [Abstract][Full Text] [Related]
18. Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes. Robinson KA; Hegyi K; Hannun YA; Buse MG; Sethi JK PLoS One; 2014; 9(10):e108963. PubMed ID: 25330241 [TBL] [Abstract][Full Text] [Related]
19. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609 [TBL] [Abstract][Full Text] [Related]
20. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism. Guridi M; Kupr B; Romanino K; Lin S; Falcetta D; Tintignac L; Rüegg MA Skelet Muscle; 2016; 6():13. PubMed ID: 27004103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]